|
LSM6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63491442606301E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.54659618445407E-11 |
| Normal-vs-Stage2 |
1.06300523938785E-11 |
| Normal-vs-Stage3 |
3.27350035966845E-10 |
| Normal-vs-Stage4 |
6.05390182428778E-11 |
| Stage1-vs-Stage2 |
1.620380E-03 |
| Stage1-vs-Stage3 |
9.798600E-01 |
| Stage1-vs-Stage4 |
9.284000E-02 |
| Stage2-vs-Stage3 |
3.200800E-03 |
| Stage2-vs-Stage4 |
1.930820E-01 |
| Stage3-vs-Stage4 |
1.009040E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.07902575763319E-12 |
| Normal-vs-AfricanAmerican |
1.39150024835999E-10 |
| Normal-vs-Asian |
1.92639999996302E-06 |
| Caucasian-vs-AfricanAmerican |
7.637700E-02 |
| Caucasian-vs-Asian |
8.178600E-01 |
| AfricanAmerican-vs-Asian |
1.790170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.87072579649339E-13 |
| Normal-vs-Female |
2.1298518504409E-12 |
| Male-vs-Female |
1.167620E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.53229992530635E-10 |
| Normal-vs-Age(41-60Yrs) |
1.95965466076586E-12 |
| Normal-vs-Age(61-80Yrs) |
1.70818914568827E-12 |
| Normal-vs-Age(81-100Yrs) |
4.878400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.178000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.157000E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.584200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.286500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.153200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.557500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.999000E-01 |
| Classical-VS-Follicular |
1.01300001720261E-09 |
| Classical-VS-Other |
4.828400E-01 |
| Classical-VS-Normal |
1.95160554383733E-11 |
| Tall-VS-Follicular |
2.433300E-04 |
| Tall-VS-Other |
4.949600E-01 |
| Tall-VS-Normal |
4.23920000000022E-05 |
| Follicular-VS-Other |
3.403000E-01 |
| Follicular-VS-Normal |
1.62458935193399E-12 |
| Other-VS-Normal |
2.358300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.11448652926083E-13 |
| Normal-vs-N1 |
3.1019999902071E-09 |
| N0-vs-N1 |
8.915400E-01 |
|
|
